These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 3827259
1. [Comparison between the succinate dehydrogenase inhibition test and ATP assay for in vitro chemosensitivity testing]. Maehara Y, Miyamoto K, Anai H, Kusumoto H, Fukuchi K, Masuda H, Sugimachi K. Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):630-4. PubMed ID: 3827259 [Abstract] [Full Text] [Related]
2. The ATP assay is more sensitive than the succinate dehydrogenase inhibition test for predicting cell viability. Maehara Y, Anai H, Tamada R, Sugimachi K. Eur J Cancer Clin Oncol; 1987 Mar; 23(3):273-6. PubMed ID: 3109921 [Abstract] [Full Text] [Related]
3. [Comparison of succinic dehydrogenase inhibition test with adenosine triphosphate inhibition assay for human solid tumors as in vitro chemosensitivity tests]. Saeki T, Jinushi K, Kim R, Kirihara Y, Takagami S, Nishiyama M, Saeki K, Niimoto M, Hattori T. Gan To Kagaku Ryoho; 1989 May; 16(5):2025-30. PubMed ID: 2730092 [Abstract] [Full Text] [Related]
5. [Experimental and clinical study in vitro chemosensitivity test for succinate dehydrogenase inhibition test]. Maehara Y, Takeuchi H, Inutsuka S, Baba H, Kohnoe S, Sugimachi K. Gan To Kagaku Ryoho; 1993 Mar; 20(4):455-60. PubMed ID: 8452383 [Abstract] [Full Text] [Related]
14. Potential application of the ATP cell viability assay in the measurement of intrinsic radiosensitivity in cervical cancer. Tam KF, Ng TY, Liu SS, Tsang PC, Kwong PW, Ngan HY. Gynecol Oncol; 2005 Mar; 96(3):765-70. PubMed ID: 15721424 [Abstract] [Full Text] [Related]
15. Comparison of the subrenal capsule assay and succinate dehydrogenase inhibition test. Iwagaki H, Fuchimoto S, Orita K. J Med; 1989 Mar; 20(3-4):251-60. PubMed ID: 2809423 [Abstract] [Full Text] [Related]
16. [The evaluation of adenosine triphosphate bioluminescence assay for chemosensitivity testing of ovarian cancer cell line]. Shi W, Gu M, Liang L. Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):79-82. PubMed ID: 8758798 [Abstract] [Full Text] [Related]
17. An in vitro short time-high dose drug exposure assay for predicting 5FU-resistance of colorectal cancer. Fan CW, Fan HA, Hsu SH, Chan CC, Chen SY, Hsu YH, Chan EC. Cancer Lett; 2004 Oct 28; 214(2):181-8. PubMed ID: 15363544 [Abstract] [Full Text] [Related]
18. Cellular basis for the inefficacy of 5-FU in human colon carcinoma. Drewinko B, Yang LY. Cancer Treat Rep; 1985 Dec 28; 69(12):1391-8. PubMed ID: 4075316 [Abstract] [Full Text] [Related]
19. Abnormal deoxyuridine suppression as a rapid predictor for antimetabolite chemosensitivity: correlation with in vitro tests of growth inhibition. Block JB, Chlebowski RT, Dietrich MF, Isacoff WH. Cancer Treat Rep; 1984 Apr 28; 68(4):631-6. PubMed ID: 6538809 [Abstract] [Full Text] [Related]
20. Clonogenic patterns of human pulmonary adenocarcinoma cell lines (PC-9, PC-13 and PC-14) and how they influence the results of test for chemosensitivity to cisplatin in the human tumor clonogenic assay. Lee YC, Saijo N, Sasaki Y, Takahashi H, Sakurai M, Ishihara J, Hoshi A, Chen KM, Hamburger AW. Jpn J Clin Oncol; 1985 Dec 28; 15(4):637-44. PubMed ID: 4094096 [Abstract] [Full Text] [Related] Page: [Next] [New Search]